Defiance Autism Impact ETF (ASD)
NASDAQ: ASD · Real-Time Price · USD
27.04
+0.09 (0.34%)
Sep 11, 2026, 4:00 PM EDT - Market closed
ASD Holdings Information
ASD is an equity ETF with a total of 41 individual holdings. The top holdings are Definium Therapeutics stock at 4.28%, Neuren Pharmaceuticals at 3.83%, LifeStance Health Group at 3.37%, ACADIA Pharmaceuticals at 3.27%, and Otsuka Holdings at 3.27%.
Total Holdings
41
Top 10 Percentage
32.86%
Asset Class
Equity
ETF Category
Health
Assets
1.35M
PE Ratio
15.02
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics, Inc. | 4.28% |
| 2 | ASX: NEU | Neuren Pharmaceuticals Limited | 3.83% |
| 3 | LFST | LifeStance Health Group, Inc. | 3.37% |
| 4 | ACAD | ACADIA Pharmaceuticals Inc. | 3.27% |
| 5 | TYO: 4578 | Otsuka Holdings Co., Ltd. | 3.27% |
| 6 | RGEN | Repligen Corporation | 3.22% |
| 7 | RVTY | Revvity, Inc. | 3.02% |
| 8 | AVXL | Anavex Life Sciences Corp. | 2.95% |
| 9 | ACHC | Acadia Healthcare Company, Inc. | 2.86% |
| 10 | JSE: LHC | Life Healthcare Group Holdings Limited | 2.78% |
| 11 | BMY | Bristol-Myers Squibb Company | 2.77% |
| 12 | BMRN | BioMarin Pharmaceutical Inc. | 2.77% |
| 13 | STO: MCOV.B | Medicover AB (publ) | 2.72% |
| 14 | ABBV | AbbVie Inc. | 2.69% |
| 15 | BFAM | Bright Horizons Family Solutions Inc. | 2.68% |
| 16 | SWX: ROP | Roche Holding AG | 2.65% |
| 17 | JNJ | Johnson & Johnson | 2.62% |
| 18 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 2.60% |
| 19 | LON: PSON | Pearson plc | 2.60% |
| 20 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 2.59% |
| 21 | EPA: IPN | Ipsen S.A. | 2.56% |
| 22 | PFE | Pfizer Inc. | 2.52% |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 2.51% |
| 24 | TYO: 4506 | Sumitomo Pharma Co., Ltd. | 2.45% |
| 25 | SWX: NOVN | Novartis AG | 2.41% |
As of Aug 27, 2026